Article Details

Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca

Retrieved on: 2022-11-28 20:01:34

Tags for this article:

Click the tags to see associated articles and topics

Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca. View article details on hiswai:

Excerpt

C4X Discovery Holdings signed a global agreement with AstraZeneca worth up to $402 million, for its NRF2 Activator program.

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up